This book discusses targeted tuberculin skin testing for latent TB infection as a strategic component of TB control. Specifically addressed are how to administer, read, and interpret the tuberculin skin test and its specificity and sensitivity. Continuing education credits are available.
This edition of the Los Angeles County Public Health Newsletter, The Public's Health, discusses World TB Day, drug-resistant TB, management of non-compliant TB patients, and the burden of TB in Los Angeles county.
This manual is a Spanish translation of Drug-Resistant Tuberculosis: A Survival Guide for Clinicians (3rd ed), 2016 by the Curry International Tuberculosis Center. It contains critical information for clinicians taking care of drug-resistant TB patients.
This report assesses how and why the IOM's tuberculosis elimination plan has not been fully implemented and provides updated action plans to move forward on its recommendations to accelerate progress toward tuberculosis elimination in the United States.
View this webinar to become familiar with the mechanism of action of Fluoroquinolones, medical trials investigating the role of Fluoroquinolones, and current recommendations and potential future roles of Fluoroquinolones in the treatment of tuberculosis.
The Global Drug Facility (GDF) is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to support the Stop TB Strategy.
This document outlines progress that GDF has made to date, what still needs to be done and where high-level advocacy could help GDF to further scale up its activities.
This form for TB patients details the actions the patient will take to avoid spreading TB.
Adopting electronic recording and reporting is not simply about choosing a piece of software: it is also about changing how people work. This is not a simple undertaking. This document introduces the key questions to be considered and illustrates what the questions, options and recommendations mean in practice by drawing on examples of recent experience from a variety of countries. It is an essential resource for all those planning to introduce electronic recording and reporting systems for TB care and control, or to enhance existing systems.
This document lists the essential research questions that will provide a common framework for various scientific disciplines to work concurrently and collaboratively towards better TB control and elimination.
The handout describes the main characteristics of LTBI and Active TB, as well as their differences. The material also describes what increases the risk for developing Active TB and how to prevent TB from developing.
